Search for: "US SECURITY ASSOCIATES INC"
Results 5781 - 5800
of 6,158
Sort by Relevance
|
Sort by Date
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
1 Aug 2008, 8:03 pm
Anyway, NullRiver, Inc. [read post]
31 Jul 2008, 10:56 am
Mon-Kota, Inc. [read post]
31 Jul 2008, 1:38 am
Most of the botulism events that are reported annually in the United States are associated with home-canned foods that have not been safely processed. [read post]
30 Jul 2008, 10:22 pm
“They told us they were going to call immigration if we complained. [read post]
25 Jul 2008, 7:04 am
Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
21 Jul 2008, 6:44 pm
The vast bulk of patents on software, business and information technology are thought by some not to be threatened because those innovations are typically implemented on a machine—namely, a computer—and the tie to a machine would provide security against the agency’s contractions of § 101. [read post]
20 Jul 2008, 11:28 pm
Although “ is only in the rarest and most compelling of circumstances that this court has acted to overturn an agency judgment not to institute rulemaking,” WWHT, Inc. v. [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge… [read post]
17 Jul 2008, 12:44 pm
Micro-Space: Richard Speck of Micro-Space, Inc. and his team hopes their "Human Lunar Lander" will secure the grand prize. [read post]
16 Jul 2008, 4:29 pm
Not only are dual-use products -- items with military and commercial uses -- subject to the EAR, but many solely commercial products as well. [read post]
14 Jul 2008, 6:05 pm
Prior art allowed underwriters to submit online bids using proprietary software to a secure computer system. [read post]
11 Jul 2008, 10:37 pm
Those attempts to find new forms of revenue have raised security issues and implicated wiretapping law. [read post]
11 Jul 2008, 4:30 am
Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
9 Jul 2008, 9:20 am
MDM Group Associates, Inc. v. [read post]
5 Jul 2008, 11:05 am
: (IP tango), China: Pfizer loses trade mark action against Jaingsu Lianhuan Pharmaceutical Co over 3D mark: (Rouse & Co International), India: More patents for new forms issued to generics: (Patent Circle), India: Gauri Kamath on drug ‘differential pricing’ in India: (Spicy IP), Mexico: Revised health supplies regulations promise changes for generics: (International Law Office), US: World drug pricing crisis: Congressmen criticise US Trade… [read post]
3 Jul 2008, 11:07 am
Copyright © 2008 Sequence Inc. [read post]
30 Jun 2008, 3:34 pm
Copyright © 2008 Sequence Inc. [read post]
27 Jun 2008, 10:04 am
Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
20 Jun 2008, 8:07 am
: (Spicy IP), Latin America: Merck Serono signs distribution agreement with Bristol-Myers Squibb for portfolio of established pharmaceutical brands in Latin America: (IP tango), US: Biotech industry growth to slow due to funding pressures and competition from biosimilars: (Managing Intellectual Property), US: House Commerce Committee posts responses to its questions on biogenerics; not surprisingly, the views run the gamut: (FDA Law Blog), US: Biosimilar debate heats up at… [read post]
